Wilmington Savings Fund Society FSB lifted its position in Danaher Co. (NYSE:DHR - Free Report) by 591.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,075 shares of the conglomerate's stock after acquiring an additional 30,855 shares during the period. Wilmington Savings Fund Society FSB's holdings in Danaher were worth $10,030,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also recently made changes to their positions in the company. nVerses Capital LLC purchased a new position in Danaher during the second quarter worth approximately $25,000. CarsonAllaria Wealth Management Ltd. purchased a new position in Danaher during the second quarter worth approximately $25,000. Teachers Insurance & Annuity Association of America purchased a new position in Danaher during the third quarter worth approximately $39,000. MidAtlantic Capital Management Inc. purchased a new position in Danaher during the third quarter worth approximately $40,000. Finally, FSA Wealth Management LLC purchased a new position in Danaher during the third quarter worth approximately $50,000. 79.05% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities analysts recently commented on DHR shares. Wells Fargo & Company started coverage on Danaher in a research report on Tuesday, August 27th. They set an "equal weight" rating and a $280.00 price objective on the stock. Stifel Nicolaus lifted their target price on Danaher from $250.00 to $265.00 and gave the company a "hold" rating in a research report on Wednesday, October 23rd. Wolfe Research upgraded Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 target price on the stock in a research report on Thursday, October 31st. Stephens restated an "overweight" rating and issued a $315.00 target price on shares of Danaher in a research report on Wednesday, October 23rd. Finally, KeyCorp lifted their target price on Danaher from $290.00 to $310.00 and gave the company an "overweight" rating in a research report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $287.16.
Get Our Latest Report on Danaher
Danaher Stock Down 0.4 %
DHR traded down $0.90 on Thursday, hitting $234.50. 3,988,403 shares of the company were exchanged, compared to its average volume of 2,786,486. Danaher Co. has a twelve month low of $219.15 and a twelve month high of $281.70. The company has a market cap of $169.37 billion, a price-to-earnings ratio of 44.93, a price-to-earnings-growth ratio of 4.23 and a beta of 0.83. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The firm has a 50-day moving average price of $248.34 and a two-hundred day moving average price of $257.78.
Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion during the quarter, compared to analysts' expectations of $5.59 billion. During the same period in the previous year, the firm posted $2.02 EPS. Danaher's revenue for the quarter was up 3.1% on a year-over-year basis. On average, equities analysts predict that Danaher Co. will post 7.5 earnings per share for the current year.
Danaher Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.46%. Danaher's payout ratio is 20.61%.
Danaher Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
